BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 209 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $300,279 | -29.2% | 12,816 | -0.2% | 0.03% | -29.5% |
| Q1 2024 | $424,365 | +21.5% | 12,844 | +0.1% | 0.04% | +131.6% |
| Q4 2023 | $349,260 | +95850.5% | 12,831 | -15.3% | 0.02% | -5.0% |
| Q3 2023 | $364 | -69.9% | 15,150 | -60.0% | 0.02% | -67.2% |
| Q2 2023 | $1,208 | -9.4% | 37,840 | -13.1% | 0.06% | +1.7% |
| Q1 2023 | $1,333 | -21.7% | 43,540 | +0.0% | 0.06% | -26.8% |
| Q4 2022 | $1,703 | -99.9% | 43,519 | -0.3% | 0.08% | -18.0% |
| Q3 2022 | $2,080,000 | +16.2% | 43,656 | -5.6% | 0.10% | +28.2% |
| Q2 2022 | $1,790,000 | – | 46,249 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $56,443,763 | 54.70% |
| HSG Holding Ltd | 796,089 | $19,145,940 | 2.05% |
| Redmile Group, LLC | 1,469,725 | $35,346,886 | 1.68% |
| ARK Investment Management | 8,783,891 | $211,252,590 | 1.62% |
| Casdin Capital, LLC | 570,000 | $13,708,500 | 1.52% |
| Deep Track Capital, LP | 1,015,641 | $24,426,166 | 0.94% |
| Yiheng Capital Management, L.P. | 560,500 | $13,480,025 | 0.69% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $103,842,825 | 0.62% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,481,839 | $107,788,228 | 0.50% |
| Alphabet Inc. | 321,604 | $7,734,576 | 0.50% |